# First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer

> **NCT06398743** · — · ACTIVE_NOT_RECRUITING · sponsor: **Exact Sciences Corporation** · enrollment: 416 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** MRD

## Key facts

- **NCT ID:** NCT06398743
- **Lead sponsor:** Exact Sciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-20
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 416 (ACTUAL)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06398743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06398743, "First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06398743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*